Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

Conditions

• Congenital Uterine Anomaly

Eligibility Criteria

Sex

FEMALE

Age

13 Years - N/A

Healthy Volunteers

Not accepted

Study Details

The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. The researchers plan to investigate whether any cancer associations (with breast, renal, ovarian, vaginal and uterine cancers) exist in females with CUAs. The investigator will also investigate any environmental and genetic factors that may be responsible for causing CUAs.

Key Dates

Start date

Jul 14, 2021

Status verified

Jun 2026

Primary completion

Aug 1, 2027

Completion

Aug 31, 2027

Study Design

Enrollment

300 participants (estimated)

Arms

• Arm: Patients with Congenital Uterine Anomalies (CUA)
  The rates of renal, breast, uterine, ovarian and vaginal cancers in women who have been diagnosed with a CUA will be studies

Primary Outcome Measure

Prevalence of breast cancer in women with CUA's compared to women without CUA's [ Time Frame: 6-months ]

Central Contacts

• Alla Vash-Margita, MD
  203-785-4010
  [email protected]
• Miranda Margetts, PhD
  [email protected]

Locations (1)

Find similar trials in New Haven, CT